Innovent’s GLORY-1 trial assessing mazdutide meets its primary endpointsInnovent Biologics has announced the key results of the first Phase 3 clinical trial of mazdutide in Chinese adults with overweight or...
US Task Force recommends intensive, comprehensive behavioural interventions for children and teens with a high BMI11 hours ago